3-(6-Chloroimidazo[1,2-a]pyridin-2-yl)aniline

Catalog No.: 
ACGYSM031
CAS No.: 
439110-86-8
Molecular Formula: 
C13H10ClN3
Molecular Weight: 
243.70
3-(6-Chloroimidazo[1,2-a]pyridin-2-yl)aniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$252.00InquiryInquiry
250mg98%$368.00InquiryInquiry
1g98%$890.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(6-Chloroimidazo[1,2-a]pyridin-2-yl)aniline
IUPAC Name3-(6-chloroimidazo[1,2-a]pyridin-2-yl)aniline
MDL No.C184547
Molecular FormulaC13H10ClN3
Molecular Weight243.70
SMILESNC1=CC=CC(C2=CN3C=C(Cl)C=CC3=N2)=C1
InChI KeyDGRUBXTUPVOPAI-UHFFFAOYSA-N
Synonym439110-86-8 | 3-(6-chloroimidazo[1,2-a]pyridin-2-yl)aniline | 3-(6-CHLORO-IMIDAZO[1,2-A]PYRIDIN-2-YL)-PHENYLAMINE | 3-(6-Chloro-imidazo[1,2-a]pyridin-2-yl)phenylamine | 3-{6-chloroimidazo[1,2-a]pyridin-2-yl}aniline | SCHEMBL6481319 | DTXSID90363196 | MFCD03012831 | AKOS0
CAS No.439110-86-8
PubChem CID1480580

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACGYSM031 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGYSM031 route product structure diagram
    ACGYSM031439110-86-8
Inquiry

2. ACGYSM031 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGYSM031 route product structure diagram
    ACGYSM031439110-86-8
Inquiry

3. ACGYSM031 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGYSM031 route product structure diagram
    ACGYSM031439110-86-8
Inquiry

Comments (0)